Mentions: Fast Company
Vancouver biotech firm AbCellera wins SIF research funding to fast-track antibody therapies against COVID-19 March 23, 2020

Mark Lowey











Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.